NT PHARMA: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024
NT PHARMA: DATE OF BOARD MEETING
NT PHARMA: SUPPLEMENTAL ANNOUNCEMENT TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2023
NT PHARMA: Annual Report 2023
NT PHARMA: ANNOUNCEMENT OF AUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
NT PHARMA: DATE OF BOARD MEETING
NT PHARMA: Interim Report 2023
NT PHARMA: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
NT PHARMA: NOTICE OF BOARD MEETING
NT PHARMA: Annual Report 2022
NT PHARMA: ANNOUNCEMENT OF AUDITED ANNUAL RESULTSFOR THE YEAR ENDED 31 DECEMBER 2022
NT PHARMA: NOTICE OF BOARD MEETING
NT PHARMA: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
NT PHARMA: Interim Report 2022
NT PHARMA: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2022
NT PHARMA: NOTICE OF BOARD MEETING
NT PHARMA: Annual Report 2021
NT PHARMA: THE AUDITED ANNUAL RESULTS FORTHE YEAR ENDED 31 DECEMBER 2021
NT PHARMA: GRANT OF WAIVER IN RELATION TO DELAY IN DESPATCH OFANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2021
NT PHARMA: (1) DELAY IN PUBLICATION OF AUDITED ANNUAL RESULTSANNOUNCEMENT AND ANNUAL REPORTFOR THE YEAR ENDED 31 DECEMBER 2021;AND(2) DATE OF BOARD MEETING
No Data